Dermatology
From the Journals
Trial gives new guidance for choosing initial PsA treatment
Adding the tumor necrosis factor inhibitor adalimumab to methotrexate because of a lack of efficacy or tolerability produced better results than...
Latest News
Adverse skin effects of cancer immunotherapy reviewed
“The desirable, immune-mediated oncologic response is often achieved at the cost of immune-related adverse events (irAEs) that may potentially...
Latest News
COVID-19–alopecia areata link? Review doesn’t find much evidence
Few reports have connected the two conditions.
Opinion
A 31-year-old female presented with a burning rash on upper arms, groin, and axillae
A 31-year-old female with a 10-year history of mild scalp psoriasis presented with a worsening itchy and burning rash on upper arms, groin, and...
Latest News
Study links air pollution to psoriasis flares
The findings underscore the need for clinicians to “consider environmental/external triggers in patients with chronic inflammatory diseases...
From the Journals
Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasis
Survival rates were highest for rituximab in rheumatoid arthritis and golimumab in axial spondyloarthritis in a study of two Danish registries.
Latest News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...
From the Journals
Methotrexate plus leflunomide proves effective for PsA
The combination therapy outperformed methotrexate monotherapy as a treatment option for patients with psoriatic arthritis (PsA), though it did...
Latest News
Managing overuse of food IgE panels: Multiple approaches needed
Beyond wasteful spending, excessive food IgE testing can lead patients to worry needlessly and to avoid foods they aren’t allergic to.
From the Journals
One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis finds
The results highlight the need for proper assessment of body weight and cardiovascular risk factors in patients with PsA at the onset of disease...
Latest News
High early recurrence rates with Merkel cell carcinoma
Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.